Clinical Trials

460 enrolled

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

NCT07549399 2026-04-24

CRITⅡ

204 enrolled

Rectal Neoplasms

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

246 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07389265 2026-02-05

CAPRI-3 GOIM

480 enrolled

Colorectal Neoplasms

NCT06998069 2025-12-30

Head and Neck Cancer Study Project in the Geriatric Population

20 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07004413 2025-06-04

FIRE-11

267 enrolled

Colorectal Neoplasms

NCT05930938 2025-05-09

XXL_2022-01

19 enrolled

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT02999087 2025-05-07

REACH

707 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02934529 2025-04-16

AIO-KRK-0114

673 enrolled

Colorectal Neoplasms

NCT01878422 2025-01-31

ITACa

376 enrolled

Colorectal Neoplasms

NCT01167725 2024-12-27

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

340 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT04687631 2024-12-18

Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases

508 enrolled

Colorectal Neoplasms

NCT06647563 2024-10-18

Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

355 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

NCT06616259 2024-09-27

CAPCET-III

452 enrolled

Colorectal Neoplasms

NCT01884623 2024-02-09

ELAN-UNFIT

82 enrolled

Head Neck Cancer Squamous Cell Recurrent

NCT04262635 2023-08-02

C-CLASSIC

80 enrolled

Colorectal Neoplasms

NCT05948072 2023-07-17

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

250 enrolled

Colorectal Neoplasms

NCT05797467 2023-05-24

Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients

366 enrolled

Colorectal Neoplasms

NCT00115700 2022-11-18

Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma

150 enrolled

Lymphoid

Lymphoma, Follicular

NCT01855451 2022-11-18

HPVOropharynx

189 enrolled

Tumor-Agnostic

Carcinoma

NCT00265811 2020-11-09

Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery

2,559 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT01107639 2020-10-20

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

297 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01969877 2020-09-02

ARTSCANIII

298 enrolled

Head and Neck Neoplasms

NCT04525326 2020-08-25

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

584 enrolled

Colorectal Neoplasms

NCT04509635 2020-08-12

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

50 enrolled

Colorectal Neoplasms

NCT00265850 2020-05-07

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

2,334 enrolled 9 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02236936 2020-05-01

AGMT_HNO_PN

8 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Hyperphagia, Laryngeal Diseases

NCT00609284 2020-04-15

2007-01

406 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02484833 2020-03-31

Erbitux MEtastatic Colorectal Cancer Strategy Study

607 enrolled

Colorectal Neoplasms

NCT00716391 2019-05-24

TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer.

519 enrolled

Head and Neck Neoplasms

NCT00077233 2018-05-16

FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

238 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00999700 2017-09-05

INTERCEPTOR

282 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT01874171 2017-05-08

De-ESCALaTE

334 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

120 enrolled

Nasopharyngeal Carcinoma

NCT01030042 2015-07-15

COMETS

110 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT01086826 2015-01-26

H&N07

320 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00433927 2014-03-14

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

568 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00004227 2014-02-06

Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx

32 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00482222 2013-01-23

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

340 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00208546 2012-02-02

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

750 enrolled

Colorectal Neoplasms

NCT00145314 2011-01-14

FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer

571 enrolled